To evaluate the safety and tolerability of SSGJ-613 after multiple subcutaneous injections in healthy subjects.
The purposes of this study are to evaluate the safety and tolerability, PK characteristics and immunogenicity of SSGJ-613 after multiple subcutaneous injections in healthy subjects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
36
Shanghai Xuhui District Central Hospital
Shanghai, Shanghai Municipality, China
Adverse events (AEs), measurement of vital signs,physical examination,electrocardiogram and laboratory tests at each visit.
The incidence and severity of treatment emergent adverse event (TEAE), including Serious Adverse Event (SAE), as well as clinical symptoms, and any abnormalities of vital signs, physical examinations,electrocardiogram,laboratory tests and, etc..
Time frame: Up to Day 174
SSGJ-613 Concentration in Serum
The concentration of SSGJ-613 in Serum.
Time frame: Up to Day 174
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.